High Tower Advisors, LLC Caribou Biosciences, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,217 shares of CRBU stock, worth $15,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,217
Previous 12,921
2.29%
Holding current value
$15,860
Previous $20,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
136Shares Held
47.1MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$8.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$5.43 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$3.92 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$3.01 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$2.82 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $73M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...